A5032857843- Renal Transplantation Outcomes and Treatments
- Organ Transplantation Techniques and Outcomes
- Microbial infections and disease research
- Glycosylation and Glycoproteins Research
- Advanced Proteomics Techniques and Applications
- Pharmacological Effects and Toxicity Studies
- Organ Donation and Transplantation
- Vibrio bacteria research studies
- HIV/AIDS drug development and treatment
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Immunotherapy and Immune Responses
- Antibiotic Resistance in Bacteria
Affiliated Hospital of Hebei University
2025
Tianjin First Center Hospital
2021-2024
Tianjin Medical University
2021-2024
Nankai University
2021-2024
Johns Hopkins University
2019
Johns Hopkins Medicine
2019
Sun Yat-sen University
2007-2013
Abstract Background Kidney transplantation is the preferred treatment for patients with end‐stage renal disease. However, acute rejection poses a threat to graft long‐term survival. The aim of this study was identify novel biomarkers detect kidney transplant rejection. Methods serum proteomic profiling T cell‐mediated (TCMR) and stable allograft function (STA) analyzed using data‐independent acquisition mass spectrometry (DIA‐MS). differentially expressed proteins (DEPs) interest were...
Prostate-specific antigen (PSA) is commonly used as a serum biomarker for the detection of prostate cancer. However, levels PSA in do not reliably distinguish aggressive cancer from non-aggressive disease. Therefore, there an urgent need biomarkers that can differentiate cancers phenotypes. Fucosylation one glycosylation-based protein modifications. Previously we demonstrated increased fucosylated patients with using lectin selection followed by immunoassay.We developed two...
Raoultella ornithinolytica is a poorly understood opportunistic pathogen, and the underlying mechanisms of its multidrug resistance pathogenicity have not yet been comprehensively investigated. The multidrug-resistant (MDR) strain WM1 was isolated from blood male patient in Tianjin, China, 2018. Here, we describe complete genome provide genomic analysis R. WM1. isolate resistant to all tested antimicrobials except amikacin, tobramycin, tigecycline. Two plasmids, pWM1-1 (IncHI5) pWM1-2...